1. Home
  2. GORO vs MDXH Comparison

GORO vs MDXH Comparison

Compare GORO & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$1.60

Market Cap

194.1M

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.66

Market Cap

183.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GORO
MDXH
Founded
1998
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Precious Metals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
194.1M
183.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GORO
MDXH
Price
$1.60
$3.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$1.75
$7.67
AVG Volume (30 Days)
11.7M
158.9K
Earning Date
11-04-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,430,000.00
$103,069,000.00
Revenue This Year
$8.76
$23.34
Revenue Next Year
$85.95
$22.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.68
52 Week Low
$0.29
$1.35
52 Week High
$1.87
$5.33

Technical Indicators

Market Signals
Indicator
GORO
MDXH
Relative Strength Index (RSI) 65.74 50.58
Support Level $0.95 $3.56
Resistance Level $1.87 $4.34
Average True Range (ATR) 0.21 0.27
MACD 0.06 0.02
Stochastic Oscillator 71.37 47.01

Price Performance

Historical Comparison
GORO
MDXH

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: